Research On Corporate Financial Strategy Under Business Model Transformation

As the Internet and big data have penetrated into all aspects of life,our lives are closely linked to the Internet era.The digital economy has become the mainstream of the new market,and the traditional industry is also facing the comprehensive challenges of emerging technologies.If enterprises want to survive and develop in the market,they must conform to the trend of the times,constantly adjust and open up innovative business models.At the same time,under the influence of factors such as the government ’s continuous reform of medical insurance payment and Internet medical policy,etc.A series of changes will take place in the medical and pharmaceutical industry.With the promulgation and implementation of various policies such as ’ zero margin ’,’ drug proportion ’,’ dual channel ’,etc.,the pharmaceutical circulation industry will be more transparent.At the same time,the pharmaceutical circulation industry and the market have also undergone tremendous changes.In the face of challenges brought by a variety of external environments,pharmaceutical circulation enterprises should conform to the development trend of the industry,seize opportunities,constantly innovate service models,give full play to the advantages that have been formed in the industry,seize opportunities in the industry reshuffle,and better create greater value for upstream and downstream customers.This paper studies and analyzes the business model of Jiuzhoutong Pharmaceutical Group Co.,Ltd.The case enterprise is the leader of China’s pharmaceutical circulation private enterprises.It has successfully completed the transformation and upgrading of business models B2 B,B2C and O2 O.In 2018,it successfully completed the transformation and upgrading of FBBC business model,which is typical and representative in the industry.Therefore,this paper chooses Jiuzhoutong Pharmaceutical Group as a case study.The paper selects the business situation and related financial strategies of the case enterprises in the past 10 years for analysis,in order to explore the successful experience and shortcomings of its business model transformation.The focus of long-term development of enterprises is the transformation of business model.As the pillar of business model transformation,financial strategy must follow the pace of business model transformation.Only by ensuring the active promotion of economic operation and business model can we ensure that enterprises can successfully complete the transformation and achieve the sustainable development of the company.This paper analyzes the process and effect of Jiuzhoutong ’s business model transformation,and analyzes how the financial strategy of the case enterprise supports its business model transformation from the perspective of financial strategy.Firstly,by analyzing the motivation of the transformation of the business model of the entire pharmaceutical circulation enterprise and the implementation of related financial strategies,the motivation and necessity of the transformation of Jiuzhoutong are obtained.Secondly,it analyzes the financial strategy and related financial problems of Jiuzhoutong from three aspects : investment,financing and profit distribution.Finally,the financial strategy matrix model is used to analyze the rationality of the financial strategy formulated by the enterprise under the business model transformation and put forward suggestions for improvement,in order to provide reference for the business model transformation of pharmaceutical circulation enterprises.